Lilly
Research Interests
Volunteers
Carrer With Us
 

Infectious Disease



  1. Clinical pharmacokinetics of alamifovir and its metabolites. Chan C, Abu-Raddad E, Golor G, Watanabe H, Sasaki A, Yeo KP, Soon D, Sinha VP, Flanagan SD, He MM, Wise SD. Antimicrob Agents Chemother. 2005 May;49(5):1813-22.

  2. Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection. Soon DK, Lowe SL, Teng CH, Yeo KP, McGill J, Wise SD. J Hepatol. 2004 Nov;41(5):852-8.